Ernexa Therapeutics Inc (ERNA)

Currency in USD
1.680
0.000(0.00%)
Closed·
After Hours
1.600-0.080(-4.76%)
·
ERNA Scorecard
Full Analysis
Impressive gross profit margins
ERNA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.6181.739
52 wk Range
1.50129.250
Key Statistics
Prev. Close
1.69
Open
1.69
Day's Range
1.618-1.739
52 wk Range
1.501-29.25
Volume
19.06K
Average Volume (3m)
78.98K
1-Year Change
-93.19%
Book Value / Share
-1.71
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ERNA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Ernexa Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

Ernexa Therapeutics Inc Company Profile

Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease. The company’s lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-102, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Compare ERNA to Peers and Sector

Metrics to compare
ERNA
Peers
Sector
Relationship
P/E Ratio
−0.3x−1.8x−0.5x
PEG Ratio
0.00−0.070.00
Price/Book
−2.1x3.5x2.6x
Price / LTM Sales
23.1x10.0x3.3x
Upside (Analyst Target)
-185.2%42.8%
Fair Value Upside
Unlock13.5%6.5%Unlock

Earnings

Latest Release
May 07, 2025
EPS / Forecast
-2.31 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ERNA Income Statement

People Also Watch

2.76
INMB
+2.60%
0.561
WINT
+5.43%
7.4100
CYCC
-9.74%
5.6600
BGLC
-1.22%

FAQ

What Stock Exchange Does Ernexa Therapeutics Trade On?

Ernexa Therapeutics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Ernexa Therapeutics?

The stock symbol for Ernexa Therapeutics is "ERNA."

What Is the Ernexa Therapeutics Market Cap?

As of today, Ernexa Therapeutics market cap is 12.44M.

What Is Ernexa Therapeutics's Earnings Per Share (TTM)?

The Ernexa Therapeutics EPS (TTM) is -26.98.

From a Technical Analysis Perspective, Is ERNA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Ernexa Therapeutics Stock Split?

Ernexa Therapeutics has split 5 times.

How Many Employees Does Ernexa Therapeutics Have?

Ernexa Therapeutics has 6 employees.

What is the current trading status of Ernexa Therapeutics (ERNA)?

As of 06 Aug 2025, Ernexa Therapeutics (ERNA) is trading at a price of 1.68, with a previous close of 1.69. The stock has fluctuated within a day range of 1.62 to 1.74, while its 52-week range spans from 1.50 to 29.25.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.